Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness

Breast cancer stem cells (BCSCs) are intrinsically chemoresistant and capable of self-renewal. Following chemotherapy, patients can develop minimal residual disease due to BCSCs which can repopulate into a relapsed tumor. Therefore, it is imperative to co-target BCSCs along with the bulk tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Sridharan, Sangita, Robeson, Megan, Bastihalli-Tukaramrao, Diwakar, Howard, Cory M., Subramaniyan, Boopathi, Tilley, Augustus M. C., Tiwari, Amit K., Raman, Dayanidhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909344/
https://www.ncbi.nlm.nih.gov/pubmed/31867270
http://dx.doi.org/10.3389/fonc.2019.01311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909344/
https://www.ncbi.nlm.nih.gov/pubmed/31867270
http://dx.doi.org/10.3389/fonc.2019.01311

Ejemplares similares